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Summary 
Natural resistance to infection with unrelated intraceUular parasites such as Mycobacteria, Salmonella, 
and Leishmania is controlled in the mouse by a single gene on chromosome 1, designated Bcg, 
lty, or Lsh. A candidate gene for Bcg, designated natural resistance-associated macrophage protein 
(Nrarnp), has been isolated and shown to encode a novel macrophage-specific membrane protein, 
which is altered in susceptible animals. We have cloned and characterized cDNA clones corresponding 
to the human NRAMP  gene.  Nucleotide and predicted amino  acid sequence analyses  indicate 
that the human NKAMP polypeptide encodes a 550-amino acid residue membrane protein with 
10-12 putative transmembrane domains,  two N-linked glycosylation sites,  and an evolutionary 
conserved consensus transport motif. Identification of genomic clones corresponding to human 
NRAMP indicates  that  the gene maps to chromosome 2q35 within  a group of syntenic loci 
conserved with proximal mouse 1. The gene is composed of at least 15 exons, with several exons 
encoding discrete predicted structural domains of the protein. These studies have also identified 
an alternatively spliced exon encoded by an Alu clement present within intron 4. Although this 
novel exon was found expressed in vivo, it would introduce a termination codon in the downstream 
exon V, resulting in a severely truncated protein.  Northern blot analyses indicate that NRAMP 
mRNA expression is tightly controlled in a tissue-specific fashion, with the highest sites of expression 
being peripheral blood leukocytes, lungs, and spleen. Additional RNA expression studies in cultured 
cells identified the macrophage  as a site  of expression of human NRAMP  and indicated that 
increased expression was correlated with  an advanced state of differentiation  of this lineage. 
T 
uberculosis remains  one of the most important  infec- 
tious diseases  worldwide and  is becoming  even more 
threatening  because of the recent emergence of multidrug- 
resistant and highly virulent strains of Mycobacterium tubercu- 
losis (1). The mechanism of host defense against M. tubercu- 
losis in general,  and the mechanisms underlying long-term 
persistence and replication  of tubercle bacilli inside mono- 
nuclear phagocytes in particular,  remain unclear and need to 
be better understood. Epidemiological studies of tuberculosis 
have suggested that initial susceptibility to infection is under 
genetic control. In addition, racial differences in susceptibility 
to invasion by M. tuberculosis, survival of certain ethnic groups 
during large epidemics, and studies with mono- or dizygotic 
twins suggest that disease establishment and progression are 
influenced by genetic factors of the host (for a review see ref- 
erence 2). Although the specific genes involved have not yet 
been identified,  recent studies suggest that such genetic factors 
may influence bactericidal activity of host macrophages to- 
ward phagocytized tubercle bacilli (3). A genetic control has 
also  been  proposed  for  susceptibility  to  leprosy,  another 
mycobacterial infection caused by Mycobacterium leprae. In this 
case, susceptibility appears to be under dual genetic control, 
with one major autosomal gene determining  susceptibility 
per se, and one gene linked to the MHC determining  the 
type and severity of disease ultimately developed (for reviews 
see references 4,  5). 
Natural  resistance  to  infection with  mycobacteria,  e.g., 
M. lepraemurium (6), M.  intracellulare (7),  and M.  bovis (8), 
is controlled in mice by the expression of a single dominant 
gene on mouse chromosome 1 designated Bcg, which con- 
trols early replication  of these bacteria in the reticuloendothelial 
system of the mouse (8,  9).  The  gene has  been shown to 
also control resistance to other antigenically unrelated intra- 
cellular parasites such as Salmonella typhimurium  (Ity; 10) and 
Leishmania donovani (Lsh; 11, 12). We have delineated the max- 
imal genetic (13) and physical (14) intervals defining the Bcg 
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several candidate transcription units for Bcg (15). One of them 
was found to be expressed exclusively in reticuloendothelial 
organs and in mature tissue macrophages, the tissues and cell 
type known to phenotypically express the genetic difference 
at Bcg (9). This candidate gene, designated Nramp 1 for nat- 
ural resistance-associated macrophage protein, was found to 
encode a novel macrophage-specific polypeptide with predicted 
features characteristic of an integral membrane protein, in- 
cluding a minimum of 10 putative trans-membrane (TM) do- 
mains and two predicted N-linked glycosylation signals (15). 
The Nramp protein also contains a conserved consensus trans- 
port motif known as the "binding protein-dependent trans- 
port system inner membrane component signature" previ- 
ously identified in a series of bacterial periplasmic transport 
proteins (16,  17). Nramp also shares  similarity through this 
motif and other predicted structural aspects with the nitrate/ni- 
trite concentrator ofAspergillus nidulans encoded by the crnA 
gene (18),  which raises  the possibility that Nrarnp may be 
involved in the metabolism/transport of oxidation products 
of nitric oxide, a key effector of the cytocidal arsenal of acti- 
vated macrophages (19, 20). Finally, nucleotide sequence anal- 
yses of the Nrarnp cDNA showed that in 27 inbred mouse 
strains of either Bcg r and Bcg  s phenotypes, the susceptibility 
trait was associated with a nonconservative glycine-to-aspartic 
acid amino acid substitution within predicted TM2 of the 
protein (21). 
The goals of the present study were to (a) clone and char- 
acterize a cDNA for the human NRAMP  homolog and ana- 
lyze the pattern of conservation between the human and mouse 
proteins with respect to the predicted structural domains of 
the two proteins in general and the region bearing the muta- 
tion found in susceptible  (Bcg') inbred mice in particular; (b) 
elucidate the genomic organization of the gene to obtain se- 
quence information required for analyzing the role of human 
NRAMP in resistance to infection in humans; (c) investigate 
the expression pattern of the human gene in normal organs 
and cells and its potential involvement in macrophage-specific 
effector functions in relation to its proposed role in the me- 
tabolism of oxidized nitrogen intermediates. 
Materials  and Methods 
cDNA Cloning and Nucleotide Sequencing.  5  x  105 independent 
clones from a human adult spleen cDNA library in X gtl0 vector 
(HL1039a; Clontech Laboratories  Inc., Palo Alto, CA) were screened 
with an EcoRI-SacII fragment of the murine Nramp cDNA as hy- 
bridization probe [position 1-1720  ofpubllshed sequence  (15)], under 
conditions of high stringency as described (22). The mouse cDNA 
probe was labeled to high specific  activity by random priming (1-2 
￿  109 cpm//zg) (23). Filters were washed under conditions of in- 
creasing stringency up to 0.5  x  SSC, 0.1% SDS at 60~  for 30 
rain. For nucleotide sequencing (24), single-stranded DNA tem- 
plates were generated from pBluescript KS+/-  subclones by su- 
perinfection with the M13 helper phage MK105. Double-stranded 
DNA plasmid templates were also used for nucleotide sequencing. 
Oligonucleotide  primers used for sequencing were either derived 
1 Abbreviations used in this paper: NRAMP, natural resistance-associated 
macrophage protein; ORF, open reading frame; TM, trans-membrane. 
from the plasmid vector or from the cDNA sequence itself. The 
complete cDNA sequence of human NRAMP cDNA was com- 
piled from the analysis of two overlapping cDNA clones, desig- 
nated H41 and H42. The nucleotide sequence data of the human 
NRAMP cDNA are available from EMBL/GenBank/DDBJ under 
accession number L32185. 
Isolation of Genomic DNA Clones  and Determination of the Exon/In- 
tron Gene Structure.  5  x  105 independent clones from a human 
genomic DNA library constructed in the BamHI site of cosmid 
vector pWE15 (22) were screened for the presence of homologous 
human  NRAMP sequences. Four independent but overlapping 
clones were purified, and their detailed restriction enzyme map was 
established for several enzymes. Oligonucleotide primers derived 
from either the plasmid vector, the human NRAMP cDNA, or 
genomic introns were used to determine the nucleotide sequence 
of genomic exons. Individual exon/intron boundaries were detected 
by a loss of identity between the genomic and cDNA nucleotide 
sequences and also by the presence of consensus donor and acceptor 
splicing signals at the point of divergence. The size of introns was 
determined by partial nucleotide sequencing, restriction mapping, 
and  PCR amplification by use of exon-derived oligonucleotide 
primers. 
Cell Culture.  The human cell lines used were obtained from 
American Type Culture Collection (Rockville, MD) and included 
the acute myelogenous leukemia KG1 (CCL246), the promyelo- 
cytic leukemia HL60 (CCL240), the histiocytic lymphoma U937 
(CRL1593), and the monocytic cell line THP1 (TIB202). Cells 
were cultured  in Dulbecco's modification of a  minimal Eagle's 
medium with a high concentration of glucose (100 mM), 10% heat- 
inactivated FCS, 2 mM glutamine, 100 U/ml penicillin, and 100 
#g/ml streptomycin (GIBCO BRL, Gaithersburg, MD). Cultures 
were maintained in a humidified atmosphere consisting of 95% 
air and 5% CO2 at 37~  by passage of 1-2  x  10  s cells/ml every 
other day. Cell viability was tested by trypan blue exclusion. 
Amplification (RT-PCR) of Human NRAMP cDNAs.  Total  or 
Poly(A)  + RNA was used as template and random hexamers as 
primers for the murine Moloney leukemia virus reverse transcrip- 
tase-mediated  cDNA  synthesis (GIBCO  BILL), as  previously 
described (25). Oligonucleotide primers HN1 (5'-CGTGGTGAC- 
AGGCAAGGA-Y, positions 417-435) and HN2 (5'-GACAAA- 
GAGGTTGATGATA-Y,  positions 988-970) were used to PCR am- 
plify  the  alternatively  spliced human  NRAMP  cDNAs.  Two 
oligonucleotide primers of sequence 5'-ACCCCCACTGAAAAA- 
GATGA-Y and 5'-GTTCAAACTTCTGCTCCTGA-3'  were used 
for control amplification of a ~2-microglobulin cDNA fragment 
(26). Reaction conditions  for PCR amplification  of  human NRAMP 
cDNA were 94~  (1 min),  50~  (1.5 min),  and 72~  (2 min) 
for 30 cycles. Reaction products were visualized  by agarose gel elec- 
trophoresis  after  ethidium  bromide  staining  and  analyzed by 
Southern blot with a 300-bp human NRAMP cDNA fragment 
generated by PCR amplification (positions 515-819) as hybridiza- 
tion probe. 
Computer-assistedAnalyses.  Analyses  of nucleotide and predicted 
amino acid sequences were performed on the VAX/VMS server 
and computer of the Universit6  de Montreal by use of the UWGCG 
software package (University of Wisconsin, Madison, WI) (27) 
and with the DNA Strider package (28). Homology searches in 
the National Center for Biotechnology Information data bases were 
performed by use of the BLAST server (National Library of Medi- 
cine,  National  Institutes  of  Health,  Rockville, MD)  (29). 
Identification and analysis of the Alu  sequences present in  the 
NRAMP gene  was performed using Alu  program  (30) of the 
PYTHIA server. 
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from normal human spleen or cultured human cells as described 
(31). PMN from heparin-treated blood were purified by centrifu- 
gation on a density gradient (HistopaqueXM; Sigma Chemical Co., 
St. Louis, MO). The polyadenylated RNA fraction was selected 
by standard chromatography on oligo (dT)-cellulose (Pharmacia 
LKB Biotechnology, Piscataway, NJ) and analyzed by Northern 
blot after electrophoresis in formaldehyde-containing agarose gel 
(22). These membranes and human multiple tissues Northern filters 
I and II (Clontech) were prehybridized in a solution containing 
10% dextran sulfate, 1 M NaCI, 1% SDS, and 200/xg/ml heat- 
denatured salmon sperm DNA for 2 h at 65~  Hybridization for 
16 h at 65~  was done in the same solution containing 2  x  106 
cpm/m132p-radiolabeled  probe (human NRAMP PCR fragment, 
position 515-819; sp act 1-2  x  109 cpm//~g DNA). Final wash 
conditions were 0.5  x  SSC, 0.5%  SDS at 65~  for 30 min. 
Results 
Isolation of NRAMP cDNA  Clones.  A  human  spleen 
cDNA library was screened under high stringency conditions 
with a mouse Nramp cDNA probe yielding five positive clones 
for a frequency of •0.001%.  Restriction enzyme mapping 
and nucleotide sequence analyses showed that these clones 
were overlapping and derived from the same mRNA species, 
although none of them were full length. The nucleotide se- 
quence of the assembled cDNA and the predicted amino acid 
sequence of the encoded protein are shown in Fig. 1 A. The 
first in-frame initiator methionine codon was found at posi- 
tion 77 of the sequence and was followed by a segment of 
1,647 nucleotides forming a single open reading frame (ORF) 
capable of encoding a protein of 550 amino acid residues with 
a calculated molecular mass of *60 kD. A TGA termination 
codon was found in the same reading frame at position 20 
upstream from the putative initiator ATG,  indicating that 
the segment upstream position 77 was untranslated. A TAG 
termination codon located immediately downstream from gly- 
cine 550 (nucleotide position 1727) was followed by an addi- 
tional 276 nucleotides of putative 3' untranslated sequence. 
No  clear  consensus  polyadenylation signal  (32)  could be 
identified within this sequence. 
Analysis of the Predicted NRAMP Polypeptide.  Analysis of 
the predicted amino acid sequence of the human NRAMP 
polypeptide revealed that is was most likely an integral mem- 
brane protein. Highly hydrophohic amino acids such as leu- 
cine (84,  15%), isoleucine (34,  6%), valine (37,  7%),  ala- 
nine (54, 10%), phenylalanine (32, 6%), and the apolar residue 
glycine (47, 9%) accounted for more than half (53%) of the 
polypeptide composition, whereas charged residues such a 
arginine/lysine (35, 6%) or aspartic/glutamic acid (34, 6%) 
accounted for only 12%. Hydropathy analysis (Fig. 1 B) sug- 
gested that  human NRAMP contained a minimum of 10 
highly hydrophobic segments, which displayed minimal charge 
density.  Although  examination  of the  NH2-terminal  se- 
quence of the protein did not reveal a classical cleavable signal 
sequence,  this region contained a high proportion of hydro- 
phylic  or  charged residues  incompatible  with  membrane 
insertion hut possibly acting as a hydrophylic cytoplasmic an- 
chor. The human NRAMP protein showed within the seg- 
ment separating putative TM domains 5 and 6, two predicted 
N-linked glycosylation sites at amino acid positions 224 (NXS) 
and 238  (NXT).  The consensus sequence motif known as 
the "binding protein-dependent transport system inner mem- 
brane component signature" (17) was found in the segment 
separating predicted TM domains 6 and 7 (positions 373-392, 
dotted underline in Fig.  1 A). This motif, which has been 
evolutionarily conserved from prokaryotes to eukaryotes, is 
predicted to be localized in cytoplasmic loops of periplasmic 
transport proteins and possibly mediates interaction of the 
hydrophobic membrane anchors with peripheral ATP binding 
subunits to energize these transporters (16). The combined 
analysis of the hydropathy profile and the location of known 
structural/functional motifs suggested the following topology 
for human NRAMP.  The NH2  terminus would be cyto- 
plasmic and followed by 10 consecutive TM domains forming 
five membrane loops, placing the COOH terminus on the 
cytoplasmic side. This arrangement would position the TM 
5-6  loop as extracytoplasmic (predicted sites for N-linked 
glycosylation), whereas the TM 6-7 loop carrying the con- 
sensus  transport motif would be intracytoplasmic. 
Homology Between Mouse and Human NRAMP Proteins. 
Comparison of the human and mouse predicted NRAMP 
protein sequences revealed a remarkable degree of conserva- 
tion  between  the  two  polypeptides,  with  88%  identical 
residues and 93% overall sequence similarity. Substitutions 
were not randomly distributed along the length of the pro- 
tein but were clustered within discrete predicted structural 
domains  (Fig.  2,  E  and  F).  The extreme NH2-  (residues 
1-50,  66%  identity)  and COOH-terminal  ends  (residues 
517-550,  74% identity) of the two proteins were the least 
conserved segments, and gaps of three residues (positions 20-22 
of mouse sequence) and one residue (position 546 of human 
sequence) had to be introduced to optimize alignment in these 
segments. In addition,  the predicted second (TM 3-4 seg- 
ment,  positions  218-240;  63%  identity)  and  third  ex- 
tracytoplasmic loops (TM 5-6 segment, positions 310-349; 
67% identity) showed significant sequence divergence. The 
fifth putative intracytoplasmic loop located between TM 8-9 
(positions 450-468; 61% identity) and the last predicted TM 
10 domain (positions 496-517; 67% identity) also contained 
a cluster of substitutions that were mainly conservative. The 
rest of the NH2-terminal third up to and including TM 3 
(residues 50-217) and the segment overlapping TM 6 to TM 
8 (residues 340-462) were the most conserved portions (97% 
identical, 99% similar;  Fig. 2, E and F). The two predicted 
phosphorylation sites by protein kinase C  identified in the 
mouse sequence (15) were not conserved in the human pro- 
tein; instead,  a new one was found within the NH2-terminal 
region (pst 54,  Fig.  1 A). By contrast, both proteins have 
retained the two predicted N-linked glycosylation sites within 
the third predicted extracellular loop (TM 5-6 interval). As 
expected, the binding protein dependent transport  system 
inner membrane component signature was highly conserved 
in human NRAMP, including a conservative arginine-to-lysine 
substitution at last position, 392, of the motif. The highly 
hydrophobic predicted membrane-associated domains of the 
proteins were strikingly conserved in the two species. Predicted 
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Figure 2.  Genomic organization of the human NRAMP gene region.  (A) Physical map of the NRAMP gene region on human chromosome  2q 
delineated by the TNP-I (2q35-36, proximal) and VIL (2q35, distal) genes. The maximal distance separating NRAMP and VIL is estimated at 220 
kb. (B) Position and relationship  of cosmid clones hybridizing to the NRAMP cDNA and used to characterize the gene. (C) The position of the 
recognition sites of restriction enzymes NotI (N), KpnI (K), EcoRI (E), and BamHI (/3) within the cosmid clones are indicated. (D) Genomic organiza- 
tion and exon/intron structure  of the human NRAMP gene. Exons are indicated by filled boxes numbered with roman numbers, whereas intervening 
and flanking sequences are represented by a thin line. The empty box between exons IV and V corresponds to the alternatively spliced Alu-derived 
exon (see text).  The direction  of transcription  is from left to right. (E) Schematic representation of the human NRAMP mRNA and the putative 
encoded product.  The thin lines represents the 5' and 3' untranslated sequences, and the boxed region indicates the mRNA coding region. The boxes 
numbered 1-10 correspond to the 10 putative  transmembrane  segments, and the solid box identifies the position of the binding-proteln-dependent 
transport  system inner membrane component signature (17). The proposed assignment of intracytoplasmic (/) and extracytoplasmic (O) loops is indi- 
cated. Arrowheads  numbered from  1-14 identify intervening sequences in the precursor mRNA. The corresponding  scales for the gene (1 kb) and 
the encoded polypeptide chain (10 amino acids) are indicated. (F/ Schematic representation of the nonidentical amino acid residue~ at homologous 
positions of the mouse and human NRAMP polypeptide chains. Conservative substitutions  are represented by short single bars, whereas nonconservative 
substitutions  are shown as long double bars. 
TM  1-8  were  identical  in  sequence (except  for  a  single 
isoleucine-to-valine conservative substitution in TM 6), in- 
cluding four charged amino acids in TM  1-3 and 7.  This 
suggests that these TM domains and residues play key struc- 
tural and/or functional roles in this protein. 
Cloning of  the Human NRAMP Gene.  Genetic linkage and 
physical  mapping  studies have established  that  the mouse 
Bcg/Nramp gene maps on the proximal portion of chromo- 
some 1, very close (125 kb) to the intestinal protein gene villin 
(14). This chromosomal region forms part of a large syntenic 
Figure  1.  Human NRAMP cDNA. (A) Nudeotide and deduced amino acid sequences of the human NRAMP cDNA. The complete nucleotide 
sequence was determined from the combined analysis of clones H41 and H42.  Nucleotides are numbered positively in the 5'-3' orientation from the 
first aucleotide identical between the H4I clone and the genomic sequence determined in this study. The deduced amino acid sequence corresponding 
to the ORF found in the nucleotide sequence is shown immediately below. Numbering starts at the first in-frame ATG and stops just before the star 
indicating the termination codon at the beginning of the 3' untranslated sequence. Potential glycosylation sites are identified by boxed residues corre- 
sponding to the consensus sequence N-X-S/T.  Predicted phosphorylation  site for protein kinase C  (S/T-X-R/K) is circled. The highly hydrophobic 
segments possibly corresponding to transmembrane domains are underlined. The protein motif  binding-protein-dependent  transport system inner mem- 
brane component signature was the only convincing functional signature identified in Bairoch's database (17) and is indicated by a dotted underline. 
A comparison of the nucleotide sequence and amino acid sequence of the corresponding OKF of the mouse Nramp cDNA is presented. Nucleotides 
and amino acid residues differing between the two sequences are shown immediately above and below the corresponding human sequence, respectively. 
(/3) Hydropathy profile (hydrophobic, positive; hydrophilic, negative) obtained for the predicted polypeptide sequence deduced from the human NRAMP 
cDNA, using Kyte and Doolittle (42) hydropathy values and a window of 11 amino acids. These sequence data are available  from EMBL/GenBank/DDBJ 
under accession number L32185. 
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Exon/intron  Exon  Intron  Intron 
number  length  Exon  end"  Exon  3' junction  Intron  5' junction  length~  Intron  3' junction  Exon 5' junction  types 
I  >73  83  ATG ACA G  gtgagtagtggc  585  gggcccccacag  GT GAC AAG  1 
II  143  226  ACA AAA CCG  gtgggatgctgg  ~1,1~  accccccaacag  GGC ACC TTC  0 
III  123  349  GGA TTC AAA  gtaactaagtcg  ~800  gcctcctcacag  CTT CTC TGG  0 
IV  120  469  TAC CCT AAG  gtgagcttgggg  ~1,2~  tcctccccatag  GTG CCC CGC  0 
v  107  576  GCT GGA CG  gtaccaccccag  ~450  ctctggtttcag  A ATC CCA  2 
VI  71  647  AAC TAC G  gtgggtgcacac  326  tctgctccgtag  GG CTG CGG  1 
vii  68  715  GGC TAT GAG  gtaggaagccag  ~3~  tcctccctgcag  TAT GTG GTG  0 
viii  156  871  CTGGTCAAG  gtgagcagaggg  ~1,5~  tgatcttcgtag  TCTCGAGAG  0 
IX  159  1,~0  CAG GCT GCG  gtgagacacact  ~1,2~  ggtacccaacag  TTC AAC ATC  0 
x  90  1,120  TAC CAG GGG  gtgagcgcgggt  87  ctcgtcctgcag  GGC GTG ATC  0 
Xl  120  1,240  GTG ATG GAG  gtagggcagggg  ~1,500  cccccaccccag  GGC TTC CTG  0 
XII  150  1,390  AGC CTG CTG  gtgagatacgcc  ~9~  tgctctccccag  CTC CCG TTC  0 
XIlI  74  1,464  AAT GGC CT  gtgagtaccccc  ~0  cgtgtcccccag  G CTG AAC  2 
XIV  154  1,618  ACC TAC CTG  gtacagtagggc  139  cccctcccccag  GTC TGG ACC  0 
XV  >389  2,007 
Consensus 
Sequences:  N  G  / G  T  R  V  G  Y  Y  Y  Y  Y  Y  N  Y  A  G  /N 
Frequency (%):  100  85.7 100  100  100  100  78.6  85  71.5 92.8  85.7  100  85.7  100  100  100  100 100 
* Positions in the eDNA sequence. 
* Length of the introns was determined by a combination of PCR and restriction enzyme mapping of genomic plasmid subclones. 
s Intron type is indicated by 0, 1, and 2 when a splice  junction occurs  between codons, after the first nucleotide  of the codon, and after the second 
nucleotide of the codon, respectively. 
N  =  A/C/G/T, IL =  A/G, Y  =  C/T/, V  =  A/G/C. 
group conserved on the long arm of human chromosome 
2 (2q32-37; reference 33), suggesting that the human NRAMP 
homolog may be located near 2q35, where the human VIL 
homolog has been previously mapped (34). Indeed, a specific 
NRAMP PCR amplification product could be obtained from 
several genomic YAC  clones containing the  VIL  gene, by 
use of sequence-specific oligonucleotide primers derived from 
the human NRAMP eDNA (data not shown).  Additional 
physical mapping of these YAC clones indicated that NRAMP 
and VIL were located on a genomic fragment of maximum 
size 220 kb (Fig. 2 A  and data not shown). To elucidate the 
genomic exon/intron organization of the human NRAMP 
gene, the mouse Nramp eDNA was used to isolate overlap- 
ping cosmid clones (Fig. 2 B). Perfect concordance was ob- 
tained between the map of the cloned region and that of the 
corresponding human genomic DNA segment deduced by 
Southern  blot  analysis  of total  genomic DNA  (data  not 
shown).  These hybridization experiments showed that the 
human NRAMP gene was present at a single copy per haploid 
genome spanning a 16-kb genomic region (Fig.  2 C). The 
gene was found to be composed of at least  15 exons (Fig. 
2 D). Their length and position within the eDNA are illus- 
trated in Fig. 2 E  and are summarized in Table 1. All splice 
donor and acceptor sites conformed to the AG/GT rule and 
gave a consensus splicing sequence for the gene, which was 
strictly in accordance with the consensus proposed by Mount 
(35).  Although exon I  was  defined as containing the first 
nucleotide of the cDNA sequence, the transcription initia- 
tion site of the gene has not yet been accurately mapped. 
Coding exons varied in size from 68 to 159 bp, whereas exon 
XV, which encodes COOH terminus of the protein and the 
3' untranslated of the mRNA, was the largest at 389 bp (Table 
1). A juxtaposition of the intron's position onto the NRAMP 
eDNA and the predicted structural features of the protein 
is shown in Fig.  2 E. The first exon encoded 76 bp of un- 
translated sequence, the proposed initiator ATG codon, and 
four additional bases. Exon II encoded a large portion of the 
intracytoplasmic NH2 terminus, whereas exon III encoded 
the rest of the intracytoplasmic domain and the beginning 
of TM 1. Likewise, exon IV encoded the rest of TM 1 and 
the beginning of the first extracytoplasmic loop, whereas exon 
V encoded the rest of the extracytoplasmic loop. Exons VI 
and VII were among the shortest in the gene, and each en- 
coded a single TM domain (TM 2 and 3, respectively). Exon 
VIII encoded the second extracytoplasmic loop and TM 4, 
exon IX the third intracytoplasmic loop and TM 5, exon X 
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of the highly conserved transport motif together with TM 
6.  Finally,  three of the remaining four TM domains were 
encoded by individual exons XII (TM 7) and XIV (TM 9-10). 
Three coding exons (II, XIV, and XV) were found to con- 
tain the majority of amino acid replacements between the 
mouse and human proteins (Fig. 2, E and F). Together, these 
results indicate a clear correlation between the organization 
of NRAMP gene exons and the predicted structural domains 
of the protein. 
Identification of an Alternatively Spliced Exon Encoded by an 
Inverted Alu Sx Element.  During the characterization of the 
human NRAMP cDNAs from the spleen library, one of the 
clones (clone H41) was found to contain an insertion of 74 bp 
at nucleotide position 470. This sequence had no homolog 
in the mouse Nramp cDNA, but its insertion corresponded 
precisely to the position of intron 4. This insertion appar- 
ently caused a frameshift in the mRNA, resulting in the ap- 
pearance of a termination codon within exon V, 32 residues 
downstream of the insertion site. To determine if the identified 
insertion was a cloning artifact or reflected the presence of 
a splicing-competent exon within the boundaries of intron 
4, the nucleotide sequence of intron 4 was determined (Fig. 
3 A). Sequence comparison of the 74-bp insertion fragment 
present in the cDNA with that of intron 4 revealed  100% 
identity with an intronic segment flanked by consensus donor 
and acceptor splicing signals.  Moreover, a homology search 
in GenBank showed that this additional exon mapped within 
the boundaries of an Alu element inserted in an inverted orien- 
tation relative to the direction of the gene transcription (Fig. 
3 A). Comparison of the sense strand of this 300-bp element 
with Alu consensus sequences gave 87% identity (Fig. 3 B) 
and allowed us to establish that this Alu sequence belonged 
to the Sx Alu family (36).  Fig.  3  C  shows the results of 
BLASTP and BLASTN analyses against the NCBI data bases, 
using either the putative truncated protein sequence or the 
Alu nucleotide sequence as query sequences, respectively. These 
analyses indicated that other mRNAs contained similar Alu- 
derived exons capable of encoding a homologous peptide se- 
quence in minor alternatively spliced isoforms. This suggested 
that a common mechanism of alternative splicing mediated 
by the Alu Sx sequence described here for the NRAMP gene 
could also occur in other genes (37-39). To determine if the 
alternative splicing event detected by cDNA and genomic 
cloning occurred in vivo and to quantitate the respective ex- 
pression levels of the two mRNAs, we tested cellular mRNAs 
for the presence of the two splice forms by RT-PCR by use 
ofNRAMP-specific oligonucleotide primers. Amplification 
products were analyzed by agarose gel electrophoresis and 
quantitated by Southern blotting  (Fig.  4  C).  Finally,  the 
authenticity of the amplification products was verified by 
nucleotide sequencing (data not shown). Results showed that 
both splice forms were indeed present in all cell lines and 
tissues tested, at an approximate ratio of 1:5, in favor of the 
mRNA species lacking the Alu-derived exon (Fig.  4  C). 
Tissue-specific Expression of NRAMP mRNA.  The pat- 
tern of tissue-specific expression of human NRAMP mRNA 
was investigated by Northern blot analysis under conditions 
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of high stringency. NRAMP mRNA expression was found 
to be highly restricted to certain tissues; in these tissues, two 
major hybridizing mRNA species of "~2 and 4 kb in size 
were coexpressed. The size of the shorter species at 2 kb was 
consistent  with  the  2,007-bp  size  of  the  reconstructed 
NRAMP cDNA  (Fig.  1 A),  suggesting  that  the cDNA 
reported here is near or full length. The origin of the larger 
4-kb mRNA remains unclear, but could result from the use 
of alternative polyadenylation signals in the gene. The site 
of highest NRAMP mRNA expression was found to be PBL. 
This very high expression was not unique to the individual 
used to produce the blot, because a comparable signal was 
obtained with  RNA  from eight additional and unrelated 
healthy volunteers (data not shown). A high expression level 
was observed in lungs and a moderate to low level detected 
in spleen and liver, respectively. Normalization of hybridiza- 
tion  signals  with actin  (Fig.  4 B)  and GAPDH  (data not 
shown) control probes revealed that NRAMP expression in 
spleen  was much higher than in liver.  The high levels of 
NRAMP expression detected in PBL, lung, and spleen, to- 
gether with the absence of expression in other tissues,  sug- 
gested that expression of this gene may be restricted to cells 
of the reticuloendothelial system such as the macrophage/ 
monocyte lineage. That possibility was further investigated 
in vitro by use of RT-PCR analysis of RNA from a series 
of human cell lines showing characteristics of this lineage. 
Cell lines KG-1, HL 60, U 937, and THP1 represent imma- 
ture precursors of the myelomonocytic lineage blocked by 
immortalization/transformation  in  a  proliferative  state  at 
different stages of differentiation towards phagocytic leuko- 
cytes (40). KG-1 cells are the closest to normal bone marrow 
precursors, whereas THP1 are closest to the monocytic cell 
type. Results shown in Fig.  4 C indicate that all cell types 
analyzed expressed NRAMP mRNA.  Interestingly, an ap- 
parent correlation between the level of expression and the 
commitment of the cell towards the phagocytic type was 
noted. 
Discussion 
Southern blot analysis of total human genomic DNA with 
the mouse Nramp cDNA probe under low stringency condi- 
tions identified two sets of hybridizing fragments, a set of 
strongly hybridizing ones and a set of a weakly cross-hy- 
bridizing  ones,  suggesting  the  presence  of at  least  two 
sequence-related NRAMP genes in humans (Vidal, S., and 
P. Gros, unpublished observations).  Therefore, high strin- 
gency conditions were used to isolate a human NRAMP 
homolog. Sequence analysis of the positive clones identified 
a very high degree of nucleotide sequence conservation with 
the mouse counterpart (Fig. 1 A), and mapping studies indi- 
cated that the corresponding human gene mapped on human 
2q35 proximal to the VIL gene on a chromosomal segment 
homologous to the portion of mouse 1 carrying Bcg/Nramp 
(Fig. 2 A) (33). Additional mapping studies excluded human 
chromosome 2 as the site for the second gene identified by 
cross-hybridization in Southern blotting (data not shown). 
Together, these results indicated that the cDNA and gene A 
I  ggtaccacgagctcaggggctttctgaggctggcctctctggctgaaggcctctccctgcctcctcacagCTTCTCTGGGTGCTGC~CTGGGCCACCGTGTTCa~GC~TGCTCTGCCAGCG  12 
L  L  W  V  L  L  W  A  T  V  L  G  L  L  C  Q  R 
24,1  cagccatt  ttcagct t  ccacgatcaaataaatacat  catct cacatqgggcat  ccaagt ct  gt  t  tgt  t  tttgt tgttgt t  tg~.~t  t  t  t  t  ca~/TCGGAGTCTCGCTCCGTCGCCCAGTC  36 
S  E  S  R  S  V  A  Q  S 
361  AGGAGTGCAATGGTC~GATGT~AGCTCA~TGCAA~CTCTACCTC~CAG~ti~at~tsattitc~t~act~i~cct~tcaauta~ct  ....  tt  ........ c  ........ tcat  ....  taa  48 
481  tttttutattttta~t  ....  ct  ....  tt  tcaccat~t tuoc  ..... ta~tct ..... tcct  ......... t  ......... acctcastctc  ...... t~ct  ....  t  taca&~cat .....  60 
601  ct~catccu=ccccaattccatttgatagat~aaagactgaggctcaactgatag ....  tacctagagggacatsagaggcatgt  (400  bp)  ggagaatcgcttgaacacgggagg  112 
1121  cggagat  t gt ggt gagccgagatcat  gccat tgcact  cca~cct  gggcaacaagag  ....  ictctatttcg  ......... a  .....  gt  t  tatctct gcctt tccatctcctgtatgctct  124 
1241  t  cct  acat  aaggt aggaagcccat  t  ggccagactgtct  agtaaatgt agt  ct  gagacgacag .....  tgtagtctgagacgacagg  .... t  ....  ggcccaccct  t  aat  gaaggatcatc  136 
1361  tcctccccatagGTGCCCCGCACCGTCCTCTGGCTGACCATCGAGCTAGCCATTGTGGC••TCCGACATGCAGGAAGTCATCGGCACCI9CCATTGCATTCAATCTGCTCTCAGCT•GACGg  148 
v  P  R  T  V  L  W  L  T  I  E  L  A  I  V  G  S  D  M  Q  E  V  I  G  T  A  I  A  F  N  L  L  S  A  G 
C  P  A  P  S  S  G  * 
14~1  ~  .........  Ag~  ......  &~o~c=~o~Aoa~c~c~o~oo~  .....  A~c~ ....  Ag~A~o~  ....  ~o~g~igc~gg~ot~  iso 
1601  ct  gcct  gt  t  t  t  ccagaat at  g  1621 
B 
I0  20  30  40  50  60  70  80  90  I00  ii0  120 
GGCCGGATC-CAGT-GCTCATGcCTGTAATCCCAGCACTTTC-C~AGACTC~GGTGGG~GGATCATCTGAGGTCAGGAGTTTGAGACCAGCCTGGCCAACATGGTGAAACCCCA~T~A~ 
130  140  150  160  170  180  190  200  210  220  230  240 
AAAAATACAAAAATTAC~CCGATGAT(9GTGGTGGGCGCCTGTAATC~A~CTACTTGAGAGGCTGAGTCAGGAGAATCACTTGTACCTGGGAGGTAGAGGTTGCAGTGAGCTGA~ATCGCA 
250  260  270  280  290 
CCACTGCACTCCAGCCTGGGCGACAGAGCGAGACTCCGTCTCAAAAAAA 
CCATTGCACTCCTGACTGGGCGACGGAGCGAGACTCCGACT~AAAAACA 
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Figure  3.  Identification  of an alternatively spliced exon encoded by an inverted Alu Sx sequence in intron 4 of the NRAMP. (A) Nucleotide sequence 
of a portion of the NRAMP  gene encompassing  part of intron 3, exon  IV (positions  71-190),  parts of intron 4, exon  V  (1373-1379),  and part of 
intron  5. The inverted Alu sequence identified  within intron 4 is underlined.  Exons  (including the alternatively spliced exon within intron 4) are in 
capital letters  in the nucleotide sequence,  and the encoded  amino acid sequences  are indicated  below.  Alternative  splicing  of the Alu-encoded  exon 
introduces  a frameshift resulting in the appearance of a termination  codon in the following exon V. (B) Nucleotide sequence alignment of the sense 
strand of the inverted Alu sequence  found in intron 4 of NRAMP (lower line) with the sense strand of the consensus  Alu sequence (upper line) gave 
87% identical positions,  indicated by stars. Analysis of the divergent positions pattern indicates that this .Alu belongs  to the Sx family (36).  (C) Polypep- 
tide sequences from other  human genes  sharing  similarity  with the predicted sequence encoded by the alternatively spliced Alu-encoded  exon.  These 
include  alternatively  spliced  exons (alt. spl.) from the DAF gene (complement decay accelerating factor; 37),  the Bls-INT gene (3-integrin;  38)  and 
a sequence from the XEH. 8c-expressed  sequence derived from a candidate gene for X-linked retinopathy (39).  Only nonidentical  residues are shown. 
Numbers in italics above each polypeptide sequence indicate  the type of intervening  sequences and position of the splice site for each particular Alu- 
encoded  sequence.  These sequence  data are available from EMBL/GenBank/DDBJ  under  accession  number L36019. 
identified here correspond to the human homolog of mouse 
Nramp. Comparison of the nucleotide and predicted amino 
acid sequences of the mouse and human NRAMP cDNAs 
revealed one important difference at the 5' end of the mRNA. 
In the previously reported mouse Nramp cDNA sequence (15), 
the first in-frame initiator methionine was followed by an 
ORF of 1,452 nucleotides,  as opposed to the 1,647 nucleo- 
tides OR/detected in human NRAMP. At the 5' end, nucleo- 
tide sequence conservation between the two species extended 
51 nucleotides upstream of the proposed murine ATG, and 
then disappeared abruptly. Translation of this 51-nucleotide 
putative 5' UT segment showed that the corresponding amino 
acid sequence would be identical to its human counterpart 
(Fig. 1 A). In addition, the abrupt loss of nucleotide sequence 
similarity between the human and mouse sequences in this 
region coincided with the position ofintron 2 in the human 
gene  (Table 1).  Subsequent $1  mapping  experiments  and 
genomic DNA sequencing verified that the 5' end of the pub- 
lished mouse Nramp cDNA sequence contains an unspliced 
intron. Additional mouse Nramp cDNA clones were there- 
fore constructed, and their analysis revealed an additional 64 
amino acid residues upstream of the previously suggested ATG 
(Govoni, G., and P. Gros, unpublished results; sequence data 
available from EMBL/GenBank/DDBJ under corrected ac- 
1748  Human Natural  Resistance-associated  Macrophage  Protein Figure 4.  Tissue-specific  expression of the human NRAMP gene in 
normal organs and cell  lines. (A) Northern blot analysis  of  NRAMP tran- 
scripts expressed in Poly(A)  + mRNA  from different normal human 
tissues, including heart (a), brain (b), placenta (c), lung (d), liver  (e), skeletal 
muscle (/), kidney (g), pancreas (h), spleen (i), thymus (/'), prostate (k), 
testis (/), ovary (m), small intestine (n), colon (o), and peripheral blood 
leukocytes  (p). (B) Rehybridization  of the blot shown  in (A) with a con- 
trol chicken ~/-actin cDNA probe. Position of size markers (in kilobases) 
are shown (arrowheads).  (C) tLT-PCR analysis of the human NRAMP 
mtLNA expression  in human cell lines representing different steps along 
the macrophage differentiation pathway: U 937 (I), THP 1 (2), KG-1 (3), 
and HL 60 (4). RT-PCR and Southern blotting were as described in 
Materials and Methods. The two hybridizing cDNA species,  corresponding 
to either the normal (555  bp) or the alternatively  spliced  Alu-derived  exon 
(639 bp) are indicated by arrows. 
cession number L13732). This novel additional sequence was 
homologous to that predicted for human NRAMP and was 
used in our analysis  (Figs.  1 A  and 2 F). During the course 
of these studies, portions of the 5' end sequence of the mouse 
cDNA and exon 2 of the human  gene were independently 
reported (41).  These partial  sequences were found identical 
to  those reported  here. 
Analysis of the full-length predicted amino acid sequence 
of the NRAMP polypeptide, including the presence of land- 
mark  functional  and structural  features,  has  led us to pro- 
pose a possible topology in which the NH2- and COOH- 
terminal segments of the protein would be intracytoplasmic 
and  separated by 10 putative TM  domains.  The  predicted 
10-TM domain configuration  has  interesting  consequences 
on the distribution  of charged residues with respect to the 
membrane.  For  positively  charged  residues  (Arg/Lys),  21 
would be intracytoplasmic,  12 would be extracytoplasmic, 
and 2 would map within predicted TM domains;  for nega- 
tively charged residues,  the corresponding distribution would 
be 20, 12, and 2, respectively, resulting in an almost perfect 
charge balance on either side and also within the membrane 
(net charge of + 1). Careful scrutiny of the hydropathy profile 
(42) and hydrophobic moment analysis  (43) of the sequence 
for the presence of hydrophobic or amphipathic  c~ helices 
identified two additional putative TM domains in the NH2- 
terminal  segment  of  NRAMP.  The  first  one  would  be 
delineated by residues 58-78 between the initiator ATG and 
the identified TM 1, whereas the second one would map at 
positions 137-158, between the identified TM 1 and TM 2. 
In addition,  these putative additional TM domains map in 
a region of the molecule that is highly conserved in the mouse 
homolog. However, the latter additional TM domain would 
be thermodynamically disfavored, requiring the stable inser- 
tion of three negatively charged residues in the membrane. 
Therefore,  NRAMP would encode a minimum  of 10 and 
a maximum  of 12 putative TM  domains. 
Sequence comparison of the human  and mouse proteins 
revealed  a remarkably high degree of conservation between 
the two species (88% identity, 93% similarity).  Whereas con- 
servation  of the  predicted  membrane  topology,  N-linked 
glycosylation signals,  and "transport  motif" was expected, 
the sequences of 10 out of the 12 possible TM domains were 
precisely conserved, including the presence of several charged 
residues in these domains. This extremely high degree of con- 
servation is somewhat surprising since conservative substitu- 
tion of hydrophobic amino acids are usually tolerated in TM 
domains  without  alteration  or  loss  of function  between 
homologs of the same proteins (44). This is of particular in- 
terest since the only amino acid sequence variation detected 
in Nramp  between inbred mouse strains  of opposite geno- 
types at Bcg is a single nonconservative  glycine-to-aspartic 
acid substitution within predicted TM 2 identified in innately 
susceptible (Beg  s) strains  (15, 21). The observation that this 
TM domain in general and glycine in particular are precisely 
conserved in human and mouse (this study) but also in the 
homologous region of the rat and chicken gene (21) strongly 
argues that  this domain is important  for function and that 
nonconservative substitutions in this region are likely to affect 
the function  of this  putative  transporter. 
Although the putative NRAMP substrate or mechanism 
of transport remain to be identified, we have detected in mo- 
lecular database searches  a few sequences locally similar  to 
NRAMP, in particular,  in the region of the consensus trans- 
port motif.  These short "expressed sequence tags" (45) are 
issued from plant genome research projects. The rice (O. sativa; 
sequence data available from EMBL/GenBank/DDBJ under 
accession  number  D15268)  and  Arabidopsis  (A.  thaliana; 
EMBL/GenBank/DDBJ accession number Z30530) protein 
sequences exhibited 46% identity (79% similarity) and 51% 
identity (73%  similarity),  respectively (Cellier,  M.,  and P. 
Gros, unpublished results).  Given the very low probability 
for these TBLASTN hits to occur by chance (p  =  5.0 e-17 
and p  =  1.7 e -~  respectively), these similarities  in primary 
amino  acid sequences are likely to reflect structural  and/or 
functional  homology  between  NILAMP  and  the  corre- 
sponding plant proteins  (29).  The intriguing  link between 
NRAMP and these plant proteins is under investigation with 
1749  Cellier  et al. respect to the "nitrate transporter" hypothesis for NRAMP 
function (15). 
The juxtaposition of intron positions on the primary amino 
acid and predicted structural features of the NRAMP poly- 
peptide revealed that the genomic organization of NRAMP 
had a highly modular structure. This is in agreement with 
previous observations suggesting that introns often mark turns 
or edges in protein secondary structure, including integral 
membrane proteins (46). Characterization of the intron/exon 
structure of the NRAMP gene revealed the presence of an 
unusual alternatively spliced exon contained within the normal 
intron 4.  Nucleotide sequence analysis of intron 4 revealed 
that this new exon was defined by consensus-splicing signals 
mapping within the boundaries of an Alu element inserted 
in a reverse orientation with respect to gene transcription. 
This Alu element was found to belong to the ancient Sx family 
of Alu sequences (50% of common Alu) (36).  The type of 
splicing event detected here and restricted to Alu elements 
inserted in the orientation opposite to transcription has been 
proposed to be an evolutionarily important mechanism for 
the generation of protein sequence diversity (49). Such inser- 
tion/splicing events have been shown to involve Alu elements 
belonging to the Sx and J subfamilies, which inserted in the 
genome at least 40 millions years ago (48), and cryptic splice 
sites could have been activated within the Alu element as a 
result of mutations subsequent to insertion (47).  Although 
both alternatively spliced forms were expressed in vivo (Fig. 
4 C), the physiological consequences of the alternatively spliced 
mRNA variant remain unclear as addition of the novel exon 
would result in a severely truncated protein. The predicted 
polypeptide encoded by the novel exon in NRAMP was similar 
to several other polypeptides surveyed (Fig.  3 C).  Interest- 
ingly, in the case of the human complement decay acceler- 
ating factor (37) and integrin 3ls genes (38),  Alu-mediated 
alternative splicing events such as that observed here have been 
shown to give rise to distinct protein isoforms with different 
subcellular localization and biological activities. 
Northern blot  analysis  revealed  NRAMP expression in 
reticulo-endothelial organs and suggested that,  by analogy 
with the mouse, the macrophage would be an important site 
of NRAMP mRNA expression in humans. In support  of 
this proposal was the observation that of four committed pro- 
genitors of the monocytic lineage blocked at different stages 
of differentiation, all expressed NRAMP (Fig. 4 C). On the 
other hand, the relative abundance of NRAMP mRNA in 
PBL compared with spleen could not be explained solely on 
the basis of different numbers of the same cell type (either 
mature macrophages or other cell type of the monocytic lin- 
eage) present at these two sites. In addition, the high levels 
of expression detected in human lungs is in sharp contrast 
to the absence of expression of the mouse homolog in the 
same tissue (15). Several possibilities  can be put forward to 
explain these findings. The first is that macrophages at different 
stages of differentiation or activation may be present in different 
amounts at these sites and may themselves express  widely 
different amounts of specific mRNA (49). This is in agree- 
ment with our finding that NRAMP expression is increased 
concomitantly with the state of differentiation of the model 
cell types used in our analysis of the monocytic pathway (Fig. 
4 C). The second possibility is that more than one cell type 
expresses NRAMP, and that cells of the granulocytic and/or 
lymphocytic pathways may also express  the gene. The ab- 
sence of NRAMP expression in adult thymus (Fig. 4 A) argues 
against a strong level of expression in lymphocytes~ The PBL 
isolation procedure used here depleted most of granulocytes; 
however we cannot exclude the possibility that the remaining 
fraction of these phagocytic cells contributed to the signal 
detected in our analysis. A third alternative is that the human 
lung RNA sample analyzed here may have originated from 
a patient with an unusually high proportion of monocytes 
or other NRAMP-positive cells brought about by specific 
infection, inflammation, or other conditions. Such cells may 
not be present in normal lung tissue from mice raised in cap- 
tivity under semisterile conditions. Finally, the levels of the 
mouse and human NRAMP mRNAs may be regulated very 
differently at the transcriptional and posttranscriptional levels 
during maturation and/or activation of the macrophage in 
the two species. This situation is reminiscent of the gene en- 
coding the inducible nitric oxide synthase expression in the 
macrophage, where strikingly different mechanisms of in- 
duction have been proposed for the two genes (50-52). The 
cloning  of genomic  sequences  reported  here  for  human 
NRAMP,  and  the  identification  of  cell  lines  showing 
differentiation-dependent expression, should help define the 
cis-acting sequences and trans-acting cellular factors control- 
ling NRAMP gene expression. 
The identification of a human NRAMP homolog, its chro- 
mosomal localization, the characterization of the nucleotide 
sequence of its cDNA, and the elucidation of the exon/in- 
tron structure of the gene reported here, together provide 
the necessary tools to test the possible  role of this gene in 
differential resistance/susceptibility of humans to infection 
with intracellular pathogens such as Mycobacteria, Salmonella, 
and Leishmania. This proposal can now be formally tested 
by segregation analysis  or direct DNA  sequencing of the 
NRAMP gene from large informative familial pedigrees from 
endemic areas of such diseases. 
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